38 related articles for article (PubMed ID: 15724390)
1. Expression of cyclooxygenase-2 and transforming growth factor-beta1 in HCV-induced chronic liver disease and hepatocellular carcinoma.
El-Bassiouny AE; Zoheiry MM; Nosseir MM; El-Ahwany EG; Ibrahim RA; El-Bassiouni NE
MedGenMed; 2007 Aug; 9(3):45. PubMed ID: 18092051
[TBL] [Abstract][Full Text] [Related]
2. A Phase II Randomized, Controlled Trial of S-Adenosylmethionine in Reducing Serum α-Fetoprotein in Patients with Hepatitis C Cirrhosis and Elevated AFP.
Morgan TR; Osann K; Bottiglieri T; Pimstone N; Hoefs JC; Hu KQ; Hassanein T; Boyer TD; Kong L; Chen WP; Richmond E; Gonzalez R; Rodriguez LM; Meyskens FL
Cancer Prev Res (Phila); 2015 Sep; 8(9):864-72. PubMed ID: 26130251
[TBL] [Abstract][Full Text] [Related]
3. Increased ΤGF-β3 in primary biliary cirrhosis: an abnormality related to pathogenesis?
Voumvouraki A; Koulentaki M; Tzardi M; Sfakianaki O; Manousou P; Notas G; Kouroumalis E
World J Gastroenterol; 2010 Oct; 16(40):5057-64. PubMed ID: 20976842
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of
Ogawa M; Moriyama M; Nakamura H; Shibata T; Kuroda K; Sugitani M
J Clin Biochem Nutr; 2024 Mar; 74(2):169-178. PubMed ID: 38510682
[TBL] [Abstract][Full Text] [Related]
5. A Possible Role for TNF-α in Coordinating Inflammation and Angiogenesis in Chronic Liver Disease and Hepatocellular Carcinoma.
Hammam O; Mahmoud O; Zahran M; Sayed A; Salama R; Hosny K; Farghly A
Gastrointest Cancer Res; 2013 Jul; 6(4):107-14. PubMed ID: 24147158
[TBL] [Abstract][Full Text] [Related]
6. Using quantitative immunohistochemistry in patients at high risk for hepatocellular cancer.
Zaidi S; Amdur R; Xiang X; Yu H; Wong LL; Rao S; He AR; Amin K; Zaheer D; Narayan RK; Satapathy SK; Latham PS; Shetty K; Guha C; Gough NR; Mishra L
Genes Cancer; 2022; 13():9-20. PubMed ID: 35677836
[TBL] [Abstract][Full Text] [Related]
7. Interactions between Myc and Mediators of Inflammation in Chronic Liver Diseases.
Liu T; Zhou Y; Ko KS; Yang H
Mediators Inflamm; 2015; 2015():276850. PubMed ID: 26508814
[TBL] [Abstract][Full Text] [Related]
8. Cytokines are associated with postembolization fever and survival in hepatocellular carcinoma patients receiving transcatheter arterial chemoembolization.
Chao Y; Wu CY; Kuo CY; Wang JP; Luo JC; Kao CH; Lee RC; Lee WP; Li CP
Hepatol Int; 2013 Jul; 7(3):883-92. PubMed ID: 26201926
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2 single-nucleotide polymorphisms and hepatocellular carcinoma in Egypt.
Mohamed FZ; Hussein YM; El-Deen IM; Sabea MS
Mol Biol Rep; 2014 Mar; 41(3):1461-8. PubMed ID: 24398550
[TBL] [Abstract][Full Text] [Related]
10. MAGE-4 gene m-RNA and TGF in blood as potential biochemical markers for HCC in HCV-infected patients.
Hussein YM; Morad FE; Gameel MA; Emam WA; El Sawy WH; El Tarhouny SA; Bayomy ES; Raafat N
Med Oncol; 2012 Dec; 29(5):3055-62. PubMed ID: 22653756
[TBL] [Abstract][Full Text] [Related]
11. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.
Basha HI; Subramanian V; Seetharam A; Nath DS; Ramachandran S; Anderson CD; Shenoy S; Chapman WC; Crippin JS; Mohanakumar T
Am J Transplant; 2011 Apr; 11(4):775-85. PubMed ID: 21446979
[TBL] [Abstract][Full Text] [Related]
12. Oxidative stress and glutathione in TGF-beta-mediated fibrogenesis.
Liu RM; Gaston Pravia KA
Free Radic Biol Med; 2010 Jan; 48(1):1-15. PubMed ID: 19800967
[TBL] [Abstract][Full Text] [Related]
13. Chemopreventive effect of selenium and Chinese medicinal herbs on N-nitrosobis(2-oxopropyl)amine-induced hepatocellular carcinoma in Syrian hamsters.
Lee CY; Hsu YC; Wang JY; Chen CC; Chiu JH
Liver Int; 2008 Jul; 28(6):841-55. PubMed ID: 18346132
[TBL] [Abstract][Full Text] [Related]
14. The Bcl-2 and TGF-beta1 levels in patients with chronic hepatitis C, liver cirrhosis and hepatocellular carcinoma.
Ali MA; Koura BA; el-Mashad N; Zaghloul MH
Egypt J Immunol; 2004; 11(1):83-90. PubMed ID: 15724390
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.
Sacco R; Leuci D; Tortorella C; Fiore G; Marinosci F; Schiraldi O; Antonaci S
Cytokine; 2000 Jun; 12(6):811-4. PubMed ID: 10843770
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients.
El Bassuoni MA; Talaat RM; Ibrahim AA; Shaker OT
Egypt J Immunol; 2008; 15(1):39-50. PubMed ID: 20306668
[TBL] [Abstract][Full Text] [Related]
17. Des-gamma-carboxyprothrombin, alpha-fetoprotein and AFP-L3 in patients with chronic hepatitis, cirrhosis and hepatocellular carcinoma.
Durazo FA; Blatt LM; Corey WG; Lin JH; Han S; Saab S; Busuttil RW; Tong MJ
J Gastroenterol Hepatol; 2008 Oct; 23(10):1541-8. PubMed ID: 18422961
[TBL] [Abstract][Full Text] [Related]
18. Impact of epidermal growth factor receptor and transforming growth factor-α on hepatitis C virus-induced hepatocarcinogenesis.
Badawy AA; El-Hindawi A; Hammam O; Moussa M; Gabal S; Said N
APMIS; 2015 Oct; 123(10):823-31. PubMed ID: 26279457
[TBL] [Abstract][Full Text] [Related]
19. The rationale for targeting TGF-β in chronic liver diseases.
Giannelli G; Mikulits W; Dooley S; Fabregat I; Moustakas A; ten Dijke P; Portincasa P; Winter P; Janssen R; Leporatti S; Herrera B; Sanchez A
Eur J Clin Invest; 2016 Apr; 46(4):349-61. PubMed ID: 26823073
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
